National and Kapodistrian University of Athens
Ο ρόλος της ενδοθηλίνης στη δευτεροπαθή πνευμονική υπέρταση σε παιδιά με συγγενείς καρδιοπάθειες και αριστεροδεξιά διαφυγή
Abstract
dc:descriptionEndothelin-1 (ET-1) is a 21–amino acid polypeptide produced by vascular endothelial cells that has vasoconstrictor properties and induces vascular smooth muscle cell proliferation. Both vasoconstriction and myofibroblast proliferation are considered to be responsible for the genesis of pulmonary hypertension (PH). Congenital heart disease (CHD) with left to right shunt type lesion is often associated with pulmonary hypertension. Endothelin-1 concentrations are increased in patients with congenital heart disease (CHD) with left to right shunt. It is unclear whether pressure or flow is the key regulator of endothelin-1 in these patients.In our study, we enrolled 31 patients with congenital heart disease, with isolated left to right shunt type lesion (atrial septal defect, ventricular septal defect and patent ductus arteriosus) and pulmonary vascular resistance less than 3 U.m. Prior to angiography was performed, a blood sample of 3 ml was obtained from the main PA and PV. Hemodynamic variables were measured during cardiac catheterization. 11 children with normal cardiac anatomy and no left to right shunt formed our control group. Plasma ET-1 levels were determined by radioimmunoassay (RIA) Endothelin 1-21 Specific [125 I] Assay System, Amersham Biosciences, UK.. Differences in patients’ profile, hemodynamics and ET-1 levels between PH and non-PH group were tested with the Mann-Whitney test and linear regression analysis. There were neither significant differences in age, nor in gender distribution among the two groups of patients (with PH and non-PH) and the normal subjects. Plasma ET-1 levels among the subgroups of patients with ASD, VSD, and PDA did not differ significantly. Also plasma ET-1 concentrations in the PH group were not significantly higher than those in the non-PH group. The Mann-Whitney U test displayed that there is no correlation between Qp/Qs and plasma ET-1 concentration of pulmonary artery (p=0.647) or pulmonary vein (p=0.133). Significant positive correlation was found between plasma ET-1 concentration at PV and mean pulmonary artery pressure (p=0.009), not only for the entire group of patients but also for two subgroups, with or without pulmonary hypertension. The multiple forward stepwise regression analysis, applied as an equivalent method, produced similar results to Mann-Whitney U test method, Conclusions: Children with the CHD of Atrial Septal Defect, Ventricular Septal Defect and Patent Ductus Arteriosus associated with left-to-right shunt, display increased plasma ET-1 levels in comparison with healthy children. Children belonging to the same group of CHD with left-to shunt and PH, develop higher ET-1 plasma concentrations compared to children without PH. Pulmonary blood pressure constitutes the main factor of plasma ET-1 levels increase in children with the above CHD and left-to-right shunt. The present study displayed that ET-1 plasma levels cannot serve as a diagnostic or prognostic indicator of disease severity, in children with the above three congenital heart diseases.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2016
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Grigoriadou, Georgia
- Γρηγοριάδου, Γεωργία
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/38355